Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Fernando Martínez-Esquivias, Juan Manuel Guzmán-Flores, Ismael Fernando Chávez-Díaz, Laura Elena Iñiguez-Muñoz & Andrés Reyes-Chaparro. (2023) Pharmacological network study on the effect of 6-gingerol on cervical cancer using computerized databases. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Read now
Luopei Guo & Keqin Hua. (2020) Cervical Cancer: Emerging Immune Landscape and Treatment. OncoTargets and Therapy 13, pages 8037-8047.
Read now
Read now
Articles from other publishers (25)
Lukas F. Mager, Tim Krause & Kathy D. McCoy. (2024) Interaction of microbiota, mucosal malignancies, and immunotherapy—Mechanistic insights. Mucosal Immunology.
Crossref
Crossref
Yashraj Potale, Yash K Kasat, Ankit Kumar & Faiz Ahmad. (2024) Unravelling the Impact of Human Papillomavirus (HPV): A Comprehensive Exploration of its Role in Cancer Progression and Global Health Challenges. BIO Web of Conferences 86, pages 01029.
Crossref
Crossref
Daniel Margul, Camilla Yu & Mariam M. AlHilli. (2023) Tumor Immune Microenvironment in Gynecologic Cancers. Cancers 15:15, pages 3849.
Crossref
Crossref
Vijay Kumar, Caitlin Bauer & John H. StewartIVIV. (2023) TIME Is Ticking for Cervical Cancer. Biology 12:7, pages 941.
Crossref
Crossref
Guang Zhu, Zhihui Xiong, Wenzeng Chen, Zhen Zhu & Wei Wang. (2023) Identification of key biomarkers and related immune cell infiltration in cervical cancer tissue based on bioinformatics analysis. Scientific Reports 13:1.
Crossref
Crossref
Daming Chu, Tengteng Liu & Yuan Yao. (2023) Implications of viral infections and oncogenesis in uterine cervical carcinoma etiology and pathogenesis. Frontiers in Microbiology 14.
Crossref
Crossref
Lingfeng Yu, Gong Lanqing, Ziyu Huang, Xiaoyan Xin, Liang Minglin, Lv Fa-hui, Hongmei Zou & Jie Min. (2023) T cell immunotherapy for cervical cancer: challenges and opportunities. Frontiers in Immunology 14.
Crossref
Crossref
Polina Dimitrova, Mariela Vasileva-Slaveva, Velizar Shivarov, Ihsan Hasan & Angel Yordanov. (2023) Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer. Medicina 59:4, pages 728.
Crossref
Crossref
Jonathan Peña Avila, Bruno Melo Carvalho & Eliane Campos Coimbra. (2023) A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities. Cancers 15:4, pages 1333.
Crossref
Crossref
T. V. Makhorina, K. E. Boeva, G. V. Malyshkina & A. V. Semenov. (2023) MECHANISMS OF EVACUATION OF THE HUMAN PAPILLOMA VIRUS FROM THE IMMUNE RESPONSE IN HIV-INFECTED PEOPLE. Laboratornaya i klinicheskaya meditsina. Farmatsiya:8, pages 46-59.
Crossref
Crossref
Adriana Gutiérrez-Hoya, Arturo Valle-Mendiola & Isabel Soto-Cruz. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
26
.
Qian Sun, Liangliang Wang, Cong Zhang, Zhenya Hong & Zhiqiang Han. (2022) Cervical cancer heterogeneity: a constant battle against viruses and drugs. Biomarker Research 10:1.
Crossref
Crossref
Ramar Vanajothi, Natarajan Srikanth, Rajendran Vijayakumar, Manikandan Palanisamy, Sundaresan Bhavaniramya & Kumpati Premkumar. (2022) HPV-mediated Cervical Cancer: A Systematic Review on Immunological
Basis, Molecular Biology, and Immune Evasion Mechanisms. Current Drug Targets 23:8, pages 782-801.
Crossref
Crossref
Ehsan Soleymaninejadian, Paola Zelini, Irene Cassaniti, Fausto Baldanti, Mattia Dominoni, Andrea Gritti & Barbara Gardella. (2022) Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, “I Am like a Box of Complexity, You Never Know What You Are Gonna Get”. Vaccines 10:5, pages 731.
Crossref
Crossref
Androniks Mitiļdžans, Tatjana Zablocka, Sergejs Isajevs, Valentīna Gordjušina & Dace Rezeberga. (2022) Upregulation of FOXP3+ Regulatory T Lymphocytes and CD8+ Lymphocytes in Patients with High-Grade Squamous Intraepithelial Lesions Correlated with HPV Infection. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 76:2, pages 218-224.
Crossref
Crossref
Alex Borin, Paola Violi, Albino Eccher, Gianluigi Zaza & Amedeo Carraro. (2022) Carcinogenesis and Cancer Progression in De Novo Anal Squamous Cell Carcinoma After Organ Transplantation: A Systematic Review. Experimental and Clinical Transplantation 20:2, pages 122-129.
Crossref
Crossref
Omar Bushara, Katrina Krogh, Samuel Edward Weinberg, Brian Steven Finkelman, Leyu Sun, Jie Liao & Guang-Yu Yang. (2022) Human Immunodeficiency Virus Infection Promotes Human Papillomavirus-Mediated Anal Squamous Carcinogenesis: An Immunologic and Pathobiologic Review. Pathobiology 89:1, pages 1-12.
Crossref
Crossref
Hoorieh Soleimanjahi & Ala Habibian. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
86
99
.
Ying Tang, Anne X.J. Zhang, Guangyu Chen, Yanheng Wu & Wenyi Gu. (2021) Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives. Molecular Therapy - Oncolytics 22, pages 410-430.
Crossref
Crossref
Zhifang Chen, Di Dong, Yuejie Zhu, Nannan Pang & Jianbing Ding. (2021) The role of Tim‐3/Galectin‐9 pathway in T‐cell function and prognosis of patients with human papilloma virus‐associated cervical carcinoma. The FASEB Journal 35:3.
Crossref
Crossref
Wei Chen, Yi Zhang, Chunfang Zhao, Suxia Shao, Yanan Zhang, Xuehui Li, Xue Bai, Qianyu Guo, Qianwen Liu, Junmin Tang & Lei Zhang. (2021) Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia. Frontiers in Immunology 11.
Crossref
Crossref
Laura Attademo, Valentina Tuninetti, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Rosa Tambaro, Giorgio Valabrega, Lucia Musacchio, Sergio Venanzio Setola, Patrizia Piccirillo, Daniela Califano, Anna Spina, Simona Losito, Stefano Greggi & Sandro Pignata. (2020) Immunotherapy in cervix cancer. Cancer Treatment Reviews 90, pages 102088.
Crossref
Crossref
Soehartati A. Gondhowiardjo, Handoko, Vito Filbert Jayalie, Riyan Apriantoni, Andreas Ronald Barata, Fajar Senoaji, IGAA Jayanthi Wulan Utami, Ferdinand Maubere, Endang Nuryadi & Angela Giselvania. (2020) Tackling Resistance to Cancer Immunotherapy: What Do We Know?. Molecules 25:18, pages 4096.
Crossref
Crossref
Rui Kuai, Priti B. Singh, Xiaoqi Sun, Cheng Xu, Alireza Hassani Najafabadi, Lindsay Scheetz, Wenmin Yuan, Yao Xu, Hao Hong, Derin B. Keskin, Catherine J. Wu, Renu Jain, Anna Schwendeman & James J. Moon. (2020) Robust Anti‐Tumor T Cell Response with Efficient Intratumoral Infiltration by Nanodisc Cancer Immunotherapy. Advanced Therapeutics 3:9.
Crossref
Crossref
Hao Ding, Guan-Lan Fan, Yue-Xiong Yi, Wei Zhang, Xiao-Xing Xiong & Omer Kamal Mahgoub. (2020) Prognostic Implications of Immune-Related Genes’ (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer. Frontiers in Genetics 11.
Crossref
Crossref